USD395499S - Dry powder inhaler - Google Patents

Dry powder inhaler Download PDF

Info

Publication number
USD395499S
USD395499S US29/052,913 US5291396F USD395499S US D395499 S USD395499 S US D395499S US 5291396 F US5291396 F US 5291396F US D395499 S USD395499 S US D395499S
Authority
US
United States
Prior art keywords
dry powder
powder inhaler
view
inhaler
elevation view
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29/052,913
Inventor
Robert F. Eisele
Karen Davies
Allan Cameron
Greg Halus
Nelson Holton
Tim Kline
Ian Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dura Pharmaceuticals Inc
Original Assignee
Dura Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dura Pharmaceuticals Inc filed Critical Dura Pharmaceuticals Inc
Priority to US29/052,913 priority Critical patent/USD395499S/en
Assigned to DURA PHARMACEUTICALS, INC. reassignment DURA PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HOLTON, NELSON, KLINE, TIM, SMITH, IAN, DAVIES, KAREN, EISELE, ROBERT, CAMERON, ALLAN, HALUM, GREG
Application granted granted Critical
Publication of USD395499S publication Critical patent/USD395499S/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Description

FIG. 1 is a perspective view of a first embodiment of a dry powder inhaler, with the cover in the open position;
FIG. 2 is a perspective view thereof with the cover in the closed position;
FIG. 3 is a plan view thereof;
FIG. 4 is a bottom view thereof;
FIG. 5 is a right side elevation view thereof;
FIG. 6 is a left side elevation view thereof;
FIG. 7 is a rear elevation view thereof;
FIG. 8 is a front elevation view thereof;
FIG. 9 is a perspective view of a second embodiment of a dry powder inhaler, with the cover in the open position;
FIG. 10 is a perspective view thereof with the cover in the closed position;
FIG. 11 is a plan view thereof;
FIG. 12 is a right side elevation view thereof;
FIG. 13 is a bottom view thereof;
FIG. 14 is a left side elevation view thereof;
FIG. 15 is a front elevation view thereof;
FIG. 16 is a rear elevation view thereof;
FIG. 17 is a plan view of a third embodiment of a dry powder inhaler;
FIG. 18 is a right side elevation view thereof;
FIG. 19 is a bottom view thereof;
FIG. 20 is a left side elevation view thereof;
FIG. 21 is a front elevation thereof; and,
FIG. 22 is a rear elevation thereof.

Claims (1)

  1. The ornamental design for a dry powder inhaler, as shown and described.
US29/052,913 1996-04-08 1996-04-08 Dry powder inhaler Expired - Lifetime USD395499S (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/052,913 USD395499S (en) 1996-04-08 1996-04-08 Dry powder inhaler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/052,913 USD395499S (en) 1996-04-08 1996-04-08 Dry powder inhaler

Publications (1)

Publication Number Publication Date
USD395499S true USD395499S (en) 1998-06-23

Family

ID=71611673

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/052,913 Expired - Lifetime USD395499S (en) 1996-04-08 1996-04-08 Dry powder inhaler

Country Status (1)

Country Link
US (1) USD395499S (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD428486S (en) * 1996-05-17 2000-07-18 Alfred Von Schuckmann Inhaler with removable mouthpiece
USD635246S1 (en) * 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
USD745660S1 (en) * 2010-03-26 2015-12-15 Oriel Therapeutics, Inc. Dry powder inhaler
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
USD767114S1 (en) 2015-03-18 2016-09-20 Amneal Pharmaceuticals Company Gmbh Inhalation device
USD769439S1 (en) 2015-03-18 2016-10-18 Amneal Pharmaceuticals Company Gmbh Inhalation device
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD428486S (en) * 1996-05-17 2000-07-18 Alfred Von Schuckmann Inhaler with removable mouthpiece
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US8912193B2 (en) 2008-06-13 2014-12-16 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US10751488B2 (en) 2008-06-13 2020-08-25 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9393372B2 (en) 2008-06-13 2016-07-19 Mannkind Corporation Dry powder drug delivery system
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8499757B2 (en) 2008-06-13 2013-08-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8636001B2 (en) 2008-06-13 2014-01-28 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US10675421B2 (en) 2008-06-20 2020-06-09 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
USD635246S1 (en) * 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
USD685461S1 (en) * 2010-03-26 2013-07-02 Oriel Therapeutics, Inc. Dose disk for a dry powder inhaler
USD745660S1 (en) * 2010-03-26 2015-12-15 Oriel Therapeutics, Inc. Dry powder inhaler
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
USD769439S1 (en) 2015-03-18 2016-10-18 Amneal Pharmaceuticals Company Gmbh Inhalation device
USD767114S1 (en) 2015-03-18 2016-09-20 Amneal Pharmaceuticals Company Gmbh Inhalation device

Similar Documents

Publication Publication Date Title
USD395499S (en) Dry powder inhaler
USD392968S (en) Communicator
USD382174S (en) Combined cup and lid
USD397273S (en) Cooler
USD396750S (en) Barbering bag
USD379506S (en) Inhaler
USD366397S (en) Storage container
USD408031S (en) Handset
USD342994S (en) Inhalator
USD374675S (en) Wireless modem
USD366989S (en) Storage container
USD419550S (en) Handset
USD391437S (en) Compact disc case
USD358708S (en) Beauty case
USD380393S (en) Combined watch and receptacle
USD403853S (en) Backpack
USD399134S (en) Package for paint
USD367589S (en) Rounded storage container
USD372180S (en) Combined whetstone and housing
USD432309S (en) Beauty case
USD432786S (en) Container
USD414987S (en) Combined cooler and stereo
USD397448S (en) Barrier
USD383605S (en) Carrying case
USD365733S (en) Lunch box